Is the Worst of the Coronavirus Behind Us Now?
(Bloomberg Opinion) -- The story of Covid-19 has been pretty bleak, from the scale of the novel coronavirus's death toll to the pain of draconian lockdowns imposed by, in many cases, unprepared and under-resourced governments.
But several weeks after the tentative lifting of tough stay-at-home restrictions in several major European countries, there are reasons to be optimistic about the risk of a second wave of cases — with a dose of appropriate caution.
In France, the government is forging ahead with the reopening of bars, restaurants, museums, parks and cross-country travel after the first phase of “deconfinement” went much better than expected. The daily increase in cases here averaged around 0.5% last week, according to Bloomberg data, and the virus's basic reproduction rate is below 1, according to the French government and other estimates based on hospitalizations.
Elsewhere, Italy, Germany and Spain have also avoided serious flare-ups in cases and deaths as restrictions are eased. It's similar in Austria and Denmark, which lifted lockdowns back in April. Weekly confirmed cases show the continuation of a declining trend. That's despite people going out and about once again, albeit with face masks and hand gel, and a stay on big-crowd events for now.
Retail and recreational footfall in these countries, which was near zero during the lockdown, has recovered to around 50% below the pre-crisis baseline, according to Google data. In parks and public spaces, it's back to normal. Consumers are even booking flights again. Visions of a radically new society emerging from the rubble of Covid-19 may have to be rethought.
There's no consensus yet on why things are going relatively well. Some experts say the virus itself may have changed, possibly weakened by the summer heat or mutating into a more benign form. Society has changed, too. More social distancing, more handwashing and more testing and contact tracing are proving their worth.
Whatever the reason, doctors are increasingly voicing relief and optimism. “Of course, we shouldn't lower our guard,” French medical professor Frederic Adnet said last week. “But right now, it's as if the epidemic was behind me.” On Friday, Christian Drosten, a virologist at the Charite University Hospital in Berlin, told Der Spiegel he was confident the outbreak could be kept under control without another lockdown: “There is theoretically a possibility that we can forego a second wave.”
None of this means that the virus has disappeared. Areas such as Latin America are still being hit hard. The World Health Organization says the strength of the virus in the developing world indicates we are globally still in the first wave, rather than past it.
Nor does it make sense for all countries to lift restrictions to the same extent. Scientists in the U.K., where daily case growth has been higher than in neighboring countries, have expressed concern about curbs being eased too fast. It's pretty unlikely we are anywhere near herd immunity, and if the virus is a seasonal one, a return in the winter months can't be ruled out.
Still, countries in Europe are proving they can return to some semblance of normal life while containing the virus's spread, and this is a very positive development. We're far better prepared to contain “super-spreader” events than at the beginning of the epidemic, when the virus thrived below the surface. Earlier this month, more than 100 infections were traced to a service in a German church, which closed its doors as a result.
And economic activity is recovering, as captured by the quite rational rally in financial markets. Bank of America analysts expect key indicators to point to an expanding euro-zone economy by September at the latest.
If infections from the novel coronavirus or another one like it do spike again, we will have had more time to keep researching existing drugs for possible treatments, as well as working on the more distant goal of a vaccine. The extra resources being poured into testing, medical research and hospitals should help us avoid the worst of both worlds — high excess deaths and blanket, economy-killing lockdown measures — even if cases climb.
The scenario of this virus simply disappearing, perhaps in the way the 2003 SARS disease did, remains a dream. Pandemics usually end when there aren't enough people left to infect, or when human intervention — through vaccines, or brute-force measures such as isolation or quarantine — scores a decisive victory. We're not there yet. But the feeling of getting closer is palpable, and worth relishing.
This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.
Lionel Laurent is a Bloomberg Opinion columnist covering Brussels. He previously worked at Reuters and Forbes.
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.